Recent advances in cell hybridization techniques have permitted the fusion of functional T cell subpopulations with tumor cells to yield stable T cell hybridomas (1-9). Such hybrids immortalize the biological activity of an individual cell and permit analysis of monoclonal T cell-derived helper (5) and suppression factors (2, 4, 6, 9, 10) . The preparation of monoclonal T cell hybridomas and isolation of biologically active factors derived from monoclonal hybridoma lines can provide a means of dissecting interacting T cell subsets that exist within heterogeneous T cell populations. Such an approach permits a more precise understanding of the mechanism of T cell interactions.
. The Ts2 cells bear anti-idiotypic receptors and function late in the immune response (13) (14) (15) . This Ts2 cell population or a soluble factor derived from it activates an antigen-primed Ts3 population that is thought to provide still another suppressor signal (i 4).
The Tsn population was first described by Sy et al. (17) in antigen-primed animals. Further analysis involving the NP system as well as the p-azobenezenearsonate suppressor system has shown that the Ts3 population possessed idiotypic, Lyt-2, and I-J determinants (14, 18) . 2 In addition, the induction of functional Ts3 cells is sensitive to cyclophosphamide (14, 17) . Despite these results, the exact mechanism by which a Ts3 population manifests immune suppression as well as the nature of the Ts3-derived factor remained unknown.
To obtain a better understanding of the precise nature and function of Ts~ cells, we prepared T cell hybridomas that corresponded to the Ts3 population. In this communication we characterize the biologically active suppressor factors (TsF~) produced by these hybridoma cells and compare these factors with previously characterized NP-specific TsF1 and TsFe factors.
Materials and Methods
Mice. All mice were either purchased from The Jackson Laboratory, Bar Harbor, Maine, or were bred in the animal facilities at Harvard Medical School, Boston, Mass. Mice were used at 3-12 mo of age and were maintained on laboratory chow and acidified, clorinated water ad lib.
Antigens. NP-O-Succinimide (NP-O-Su) was purchased from Bioseareh Co., San Rafael, Calif. Dimethylsulfoxide (DMSO) was purchased from Fisher Scientific Co., Pittsburgh, Pa. 2,4-dinitro-l-fluorobenzene (DNFB) and keyhole limpet hemocyanin (KLH) were obtained from Sigma Chemical Co., St. Louis, Mo.
Antisera. Both B10.A(3R) anti-B10.A(5R) (anti-I-J k) and B10.A(5R) anti-B10.A(3R) (anti-I-J b) were produced by immunization with spleen and lymph node cells, as described elsewhere (4) . Both monoclonal anti-Thy 1.1 and Thy-1.2 antibodies were ~urchased from New England Nuclear, Boston, Mass. Guinea pig anti-CGAT and anti-NP anti-idiotype antisera were prepared as detailed elsewhere (12, 19) . The characterization of these reagents that detect a common idiotype on anti-GAT and anti-NP antibodies, respectively, was described previously (4) .
Preparation of Tsa CeUsfrom Antigen Plates.
The methods for the preparation and enrichment of NP-binding T cells were described in detail elsewhere (12) . 2 In brief, 5 × 107 regional lymph node or spleen cells from CKB(H-2 k, Igh-1 b) and C57BL/6 (H-2 ~, Igh-I ~) mice, which were immunized subcutaneously with 2 mg NP-O-Su or with 100 /~g NP-KLH i.p. in Maalox Perlussis (15) , were added to purified anti-mouse immunoglobulin (RAMG)-coated petri dishes to remove B cells. The nonadherent T cells were incubated on NP-bovine serum albumincoated petri dishes for 45 min at room temperature. Nonadherent cells were removed by gentle swirling, and the plates were placed on ice for 20 min. The antigen-binding cells were collected from the plate by gentle pipetting and used as the source of Ts3 cells.
Hybridization and Screening of Ts3
Hybridoma Lines. Tsa-enriched CKB or C57BL/6 lymphocytes were hybridized with BW5147 T lymphoma cells. The polyethylene glycol-mediated hybridizing method was exactly the same as previously reported (4) . The hybridized Ts~ candidates were screened using a cytotoxicity test (4) with allele-specific anli-I-J and anti-NP ~' antisera. Three fusions were performed; the CKB-Ts3-3 and CKB-Ts:~-9 lines were derived from one fusion using CKB NP-O-Su-primed lymph node cells. The B6-Ts3-2 line was similarly derived from a fusion between NP-O-Su-primed lymph node cells from C57BL/6 mice and BW5147 2 Sherr, D. It., and M. E. Dorf. Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XIII. Characterization of a third-order T cell (Tss) involved in suppression of in vitro PFC responses. Manuscript in preparation.
tumor cells. The B6-Ts3-19 line was obtained from a third hlsion using antigen-adherent splenic T cells from an NP-KLH-primed C57BL/6 mouse. In addition, the B6-Tsa-8 hybridoma line was derived from still another fusion in which we were screening for Tsz hybrids (Minami and Okuda, unpublished observations). All the Tsa hybrids were periodically passaged over the antigen-coated plates, and the idiotype-adherent cells were used to maintain the cell lines. The B6-Tsa-2, CKB-Ts3-3, and CKB-Ts3-9 hybridoma lines were cloned by limiting dilution; l0 of the 11 clones tested had the same phenotype and suppressive activity as the parental line, but one CKB-Tsa-3 clone lacked functional activity.
All of the hybridomas were cultured in RPMI 1640 containing 8% fetal calf serum and 0.01 M Hepes buffer. The suppressor factors used in the present experiment were collected from the cultured supernatants of cells at an approximate density of 7 × 105 cells/ml in the above medium.
Adsorption and Elution of TsF. The methods of absorption and elution of TsF using proteinconjugated Sepharose-4B columns were described in detail previously (4) .
Assay for Suppressive Activity of TsF on NP-mediated Cutaneous Sensitivity (CS) Responses.
The assay for NP-specific CS responses was described elsewhere (10, 14) . Briefly, each animal was primed subcutaneously with 2 mg of NP-O-Su in DMSO. Unless indicated otherwise, the hybridoma factors were tested in the effector phase, 5 or 6 d after priming. 0.4 ml of each hybridoma supernatant or BW5147 control supernatant was injected i.v. on the day before and the day of antigen challenge. 6 d after immunization, mice were challenged in the left footpad with 0.025 ml phosphate-buffered saline (PBS) solution containing 30 p,g of NP-O-Su (prepared by mixing 25 ~1 of a 2% NP-O-Su/DMSO solution in 0.4 ml PBS). Footpad swelling 3 was measured 24 h after challenge. Swelling was determined as the difference, in units of 10-' cm, between the left and right footpad thickness. Data Analysis. Statistical analysis of the experimental data with respect to controls was calculated using the two-tailed Student's t test.
Functional Analysis of TsF~ and TsFa Factors in

Results
Screening of Hybridoma Suppressor Cells. After fusion of antigen-adherent T cells from NP-primed mice with AKR-derived BW5147 tumor cells, 320 of 2,300 wells developed hybridoma colonies. 260 of these 320 lines were screened by the microcytotoxicity test using allele-specific anti-I-J alloantisera. 26% were specifically lysed with anti-I-J alloantisera. 54 of these lines were then screened with guinea pig anti-NP b or control anti-CGAT-anti-idiotypic antisera; 39% (21 of 54) of these lines were specifically lysed with anti-NP b idiotype antisera. Supernatants from those lines that were specifically lysed with both anti-I-J and anti-NP b were tested for suppressive activity by administrating 0.4 ml of supernatant the day before and the day of antigen challenge. At least seven lines demonstrated significant levels of supppessive activity. Five of those that demonstrated >50% suppressive activity of the NP-O-Su CS response were selected for further phenotyping and characterization. The five hybridoma lines that constitutively produced suppressor factor were B6-Tsa-2, B6-Ts3-8, B6-Tsa-19, CKBTsa-3, and CKB-Tsa-9. Upon retesting, two of the lines (B6-Tsa-8 and B6-Ts3-19) demonstrated variable or no reaction with the anti-I-J b or the anti-NP b idiotypic antisera, although these hybridomas retained their ability to secrete a biologically active suppressor factor (see below). It is not clear why these lines were screened as initially positive, but after continual culture, they appeared to lose their ability to express I-J and idiotypic determinants on their cell surface. Clones of each of these lines were also tested for the presence of I-J and idiotypic determinants, and again the clones appeared to have little or no expression of these antigenic determinants. In contrast, the other three lines have maintained the ability to express cell surface I-J and idiotype determinants.
Specificity of Suppressor Factors.
To test the biological activity of these presumptive suppressor hybridomas, we screened for the ability of culture supernatants obtained from cells growing at an approximate density of 7 X 105 cells/ml to suppress in vivo CS responses. As shown in Table I , injection of 0.4 ml of culture supernatant from the B6-Tsa-2, B6-Tss-19, and CKB-Tsa-9 cell lines specifically suppressed NP-O-Su-in- 25.8 ± i.:
* Groups of four to five mice were immunized with either NP-O-Su or DNFB, The day before and the day of antigen challenge mice were given an i.v. injection of 0.4 ml of either control BW5147 or suppressor factor. The background responses of nonimmunized C57BL/6 mice were 4.1 ± 0.7 and 11.2 "4-1.2 for NP-O-Su and DNFB, respectively. The background responses of CKB mice were 3.0 ± 0.4 and 2.6 + 0.7 for NP-O-Su and DNFB, respectively. * Significant suppression, P < 0.005. duced CS responses. The culture supernatants demonstrated maximum plateau levels of activity when given either undiluted or diluted 1:10. In these experiments the percent of suppression ranged from 50-75%. After further dilution these materials no longer demonstrated significant levels of suppressive activity.
The antigen specificity of these suppressor factors was initially demonstrated by their inability to suppress the DNFB-induced contact sensitivity responses (Table I) . The NP specificity of the B6-Tsa-8 and CKB-Tsa-3 suppressor factors was similarly established (data not shown).
Although the specificity of these suppressor factors was demonstrated by the above criteria, it could still be argued that specific antigen is only required to trigger the suppressive activity, and once triggered, the suppression would be nonspecific. Several examples of such antigen-dependent nonspecific suppression have been noted in the literature (22) (23) (24) . To evaluate the latter possibility, groups of four to five C57BL/6 mice were immunized with either DNFB alone or DNFB plus NP-O-Su. After 5 d, the animals were given either control BW5147 supernatants or culture supernatants from B6-Tsa-2 or B6-Ta-19 cells. The mice were then challenged in the left ear by painting with DNFB, injecting 7.0 #g NP-O-Su in 15/.tl PBS (pH 7.7), or with both antigens. The incremental ear swelling was measured at 24 and 48 h. The data in Table II verify specificity of the B6-Tsa-2 and the B6-Tsa-19 factors. Thus, these latter factors fail to suppress ear swelling responses induced and elicited with DNFB or responses induced with NP-O-Su plus DNFB priming and elicited with DNFB alone. However, the activity of the B6-Tsa-2 and B6-Ts3-19-derived factors was confirmed by their ability to suppress ear swelling responses in mice primed with both NP-O-Su plus DNFB and challenged with NP-O-Su alone. To determine whether these 
BW5147
NP-O-Su + DNFB 10.5 ± 1.2 6.5 ± 1.0 * Groups of four to five mice were primed with DNFB alone or with DNFB and NP-O-Su. 5 and 6 d thereafter, they were given TsF or control factors, followed by ear challenge with DNFB, NP-O-Su, or both antigens. The specific ear swelling responses were measured 24 and 48 h after challenge. The data are expressed as the increment of ear swelling (× 1() -:~ cm) + SE. :~ Significant suppression, P < 0.005. suppressor factors would nonspecifically suppress DNFB responses when the animals were challenged with both NP-O-Su plus DNFB, another series of animals were tested. As shown in Table II , the presence of NP-O-Su in the challenge site is not sufficient to suppress DNFB-induced contact sensitivity responses. Thus, the data demonstrate that these hybridoma-derived suppressor factors are antigen specific.
Effector-Phase Suppression. To compare this series of NP-specific suppressor factors with the previously characterized Tsl-and Ts2-derived hybridoma factors, we determined when in the course of the immune response the various factors were active. 0.4 ml of factor was injected i.v. either on the day of and the day after antigen priming (induction phase) or the day before and the day of antigen challenge (effector phase). As previously reported (10), the B6-Tsl-29-and CKB-Tsl-17-derived control TsF1 factors only demonstrated suppressive activity when administered during the induction phase of the immune response (Table III) . In contrast, the previously characterized B6-Ts2-28-derived TsF2 factor (20) and the five new hybridoma factors were only active when administered in the effector phase of the NP-O-Su CS response (Table  III) .
Genetic Restrictions of Hybridoma Suppressor Factors.
To further compare this new series of hybridoma suppressor factors with those previously characterized, the genetic restrictions of this new series of factors was determined in comparison with the monoclonal control Tsl-and Ts2-derived factors. The Tsl factor was administered during the induction phase of the immune response, whereas the Ts2 and the new series of suppressor factors were administered during the effector phase. As shown in Table IV and in confirmation of previous data (10, 20) , the C57BL/6-derived TSl factor from the B6-Ts1-29 cells suppressed NP-specific CS responses in both syngeneic strains are both congenic with respect to the Igh complex, the data suggest that the Tsz and the presumed Ts3-derived factors are restricted by genes in both the Igh and H-2 complexes. It should be noted that the B6-Tsa-2 cells that produced this factor were a cloned subline. In another series of experiments, factors derived from cloned sublines of CKB-Tsa-3 and CKB-Tsa-9 cells were also shown to be both H-2 and Igh restricted (data not shown). Variations in the magnitude of the NP-specific CS responses in different inbred strains were noted in the data shown in Table IV . This variation appears to correlate with the age of the recipient mice; older animals generally yield larger footpad swelling responses (unpublished observations).
To determine which subregion of the H-2 complex restricted suppressor factor activity, control B6-Ts2-28-derived TsF2, which was previously shown to be I-J b restricted (20) , and the new series of hybridoma-derived factors were tested in * Hybridoma-derived TsF containing supernatant fluids were adsorbed onto various columns and the unbound and acld-eluted fractions were tested for suppressive activity in either C57B1/6 or BI0.BR recipients. The results using the control B6-Tsl-'29 and B6-Ts2-28-derived TsF were previously published (20) . The data are expressed as the percent suppression of the NP-CLSu CS response compared with BW5147 supernatant controls. Less than 3017~, suppression is not significant. patible B10.A(4R) recipients. Thus, it appears that I-J homology is required between both the factor donor and recipient strains for TsF2 and TsFa functional activity.
Immunochemical Characterization of Suppresor Factors. In further attempts to distinguish
the Ts2-and the presumed Tsa-derived factors from each other and from the previously described TsF1 factors, selected factors were passed over a series of immunoadsorbent columns. The suppressive activity of the C57BL/6(H-2b)-derived factors could be depleted by passage over anti-IJ b columns but not anti-IJ k columns. In contrast, CKB-Ts3-9 (H-2k)-derived factor was specifically adsorbed by anti-IJ k columns. The suppressive activity could be recovered by acid elution (Table VI) . The suppressive activity of the Tsl, Ts2, and the new series of hybridoma factors were not adsorbed by polyvalent guinea pig anti-immunoglobulin columns that were reactive with #, 7z, 72a, yZb, ~, and ~ chains. However, the Tsl and the new series of hybridoma factors were adsorbed by guinea pig anti-idiotype columns and NP-KLH columns. This contrasts the results obtained with B6-Ts2-28-derived factor, which could not be adsorbed by either anti-idiotype or NP-KLH immunoabsorbent columns (Table VI  and reference 20) . However, B6-Ts2-28-derived TsF2 lacks an NP binding site and in contrast to the other factors could be depleted on NP b idiotype columns. The specificity of adsorption was controlled by demonstrating that suppressive activity could be recovered by acid elution from the appropriate columns. Thus, we conclude that this new series of hybridoma factors bear I-J and idiotypic determinants and have a specific receptor for NP hapten. These features distinguish the new series of effector-phase hybridoma-derived suppressor factors from the previously described TsF2 suppressor factors (20) .
Activity of TsF in Cydophosphamide-treated Recipients. Previous reports (14, 17) dem-
onstrated that the precursor Tsa cells were sensitive to cyclophosphamide treatment.
To further compare Tsz-and Tsa-derived suppressor factors, hybridoma TsF~ and TsFa were administered to animals that were treated with 50 mg/kg of cyclophosphamide 1 d after antigen priming. The hybridoma-derived suppressor factors were administered during the effector phase of the immune response. As shown in Table  VII , cyclophosphamide pretreatment does not alter the magnitude of the NP-specific CS response. Furthermore, B6-Tsz-28-derived factor failed to suppress cyclophosphamide-treated mice, whereas the B6-Ta-8-and B6-Tsa-19-derived factors were active in cyclophosphamide-treated recipients. Similar results were noted with CKB-derived TsF2 and TsFa factors (data not shown). These results suggest that TsF~ activates a cyclophosphamide-sensitive Tsa target population and that TsF3 can replace the requirement for this cyclophosphamide-sensitive antigen-primed suppressor cell population.
Discussion
This report characterizes a new series of suppressor cell hybridoma lines. Five T cell hybridoma lines have been characterized. These new hybridomas differ from the two * Groups of four to five mice were immunized with NP-O-Su, and 24 h later some groups were given 50 mg/kg cyclophosphamide i.p. During the effector phase of the CS response the animals were given 0.4 ml of TsF/d. The data are expressed as the increment of footpad swelling ± SE in units of 10 -3 cm. ~: Significant suppression, P < 0.001. other types of NP-specific suppressor T cell hybridoma lines previously characterized (10, 20) . First, the cells used for fusion are primarily derived from mice that have been immunized with either NP-O-Su or NP-KLH. In the past, we have used spleen cells from animals that were tolerized by intravenously administering NP-coupled syngeneic cells. However, we obtained one Ts3 hybridoma line from spleen cells of mice that were tolerized with NP-coupled syngeneic cells. Although this demonstrates that Tsn cells were also present in tolerized animals, the frequency of such cells must be very low. Thus, only one such hybridoma line has been discovered after the screening of several thousand hybridomas from animals that were tolerized with NPcoupled syngeneic cells.
This new series ofT cell hybridomas bear allele-specific I-J cell surface determinants and generally bear Npb-related idiotypic determinants. The presence of Thy-l.2 marker on most of the hybridoma lines and the Lyt-2.2 marker on the B6-Tss-19 hybridoma (data not shown) is consistent with the previously reported phenotype of the Ts3 population. In a few cases, phenotyping for the Lyt-2.2 marker was not possible because two different monoclonal reagents gave disparate results.
The suppressor factors derived from these hybridoma cell lines were also characterized. The TsFs suppressor factors differed from the previously characterized TsF1 and TsF2 factors. TsF3 factor acts during the effector phase in contrast to TsF1 factor, which is active only during the induction phase of the CS response. It is not clear why TsF2 or TsF3 factors function only during the effector phase and do not mediate suppression when given during the induction phase of the CS response. One possibility is that these materials have a very short biological half-life. Alternatively, the timing of factor administration with respect to the occurrence of an appropriately differentiated target cell population might be critical.
The antigenic properties of TsFs were determined by passing these factors over a series of immunoadsorbent columns. Ysa-and Tss-derived factors had similar characteristics. First, both factors bore I-J alad NP b idiotypic determinants and bound to antigen columns; all the suppressor factors lacked constant region immunoglobulin determinants. As reported elsewhere (20) , TsF2 factor bound to idiotype columns and apparently possessed an anti-idiotypic receptor (Table VI) .
To further distinguish TsF3 factor than TsF1 and TsF2 factors, the genetics of factor activity were analyzed. TsFa factor, like TsF~ factor, only suppressed strains that were matched at both the Igh and H-2 gene complexes (Table IV) . In contrast, TsF1 factor lacks at least H-2 i'estrictions, but as described elsewhere (10), is pseudo-restricted by genes in the Igh complex. To further distinguish the TsF3 factors from the TsF2 effector-phase factors, the activity of these factors was tested in animals that had been treated with cyclophosphamide. TsFz factor failed to suppress cyclophosphamidetreated mice, whereas TsFa factor retained its activity in animals pretreated with cyclophosphamide (Table VII) . Finally, the target cells of each type of suppressor factor are distinct. Thus, TsF1 functions by inducing a Ts2 population, whereas Ts2 factor appears to trigger a cyclophosphamide-sensitive Ts3 cell population. The target cell of the TsFs factor is unknown. Table VIII summarizes the similarities and differences between Tsl, Ts2, and Tsa cells and the factors derived from these cells.
The literature describes many suppressor cell systems, some of which appear to be antigen specific (24) (25) (26) (27) (28) (29) , whereas others demonstrate elements of nonspecificity (21) (22) (23) 28) . The NP system has been shown to be specific in this and in previous reports (10, 14, 15) . The experiments using animals primed or challenged with DNFB together with NP-O-Su strengthen the conclusion that the suppression mediated in the NP system is antigen specific (Table II) . The fact that TsF3 factor is Igh restricted differs from the observations in some suppressor cell systems (18, 22, 29) . There are several possible explanations for these apparently disparate results. First, the systems and the methods used are quite different in the various suppressor models studied. The different methods for evaluating specificity might account for the results observed. It is noteworthy that Fresno et al. (26) have characterized a specific TsF3-1ike factor, which upon cleavage or partial degradation becomes antigen nonspecific. We have not evaluated this possibility in our system. An alternative possibility is that there are several Ts3-1ike cells, some of which mediate nonspecifie suppression. If the latter is true, we must conclude that in the NP system the antigen-specific Igh-restricted Ts3 population appears to predominate.
The Ts3 factors show dual genetic restriction, requiring both I-J and Igh region homolog~ for factor activity. Such findings of dual genetic restrictions are not unique to the NP system nor the TsF3-derived factors. Thus, Suzuki et al. (16) and Dietz et al. (30) have recently also reported dual genetic restrictions of suppressor factors. The fact that Igh restrictions are observed suggests that idiotype-anti-idiotype interactions are required between TsF3 and its target cells. Furthermore, these Igh restrictions argue against an antigen-bridging mechanism occurring between the TsF3 and its target cells. The results imply, therefore, that the target of TsF3 might be an antiidiotypic suppressor or helper cell population. At the present time, we are attempting to characterize this target population. The I-J restrictions observed with TsF3 factor might reflect a requirement for an acceptor site on the target cell population that is required for triggering or inactivating the target cell. Alternatively, they might reflect a pseudo-genetic restriction similar to that previously characterized for TsF1 factors (10).
The Ts3 cells described in this report constitutively secrete TsF3 factor. This suggests that some of the Ts3 cells are normally present in antigen-primed animals. These Ts3 appear to be fully differentiated and might be involved in the autoregulation of the NP-specific immune response. The question of how these Ts3 cells are activated remains unanswered. One possibility is that a few Ts2 cells also exist in antigenprimed mice and these Ts2 cells release TsF2 factor that activates a small percentage of the Tsz population. Another possibility is that Tsz ceils might also be activated by other means, e.g., anti-idiotype antibody. Finally, we cannot exclude the possibility that in situ the Tsz cells were not actively secreting TsF8 factor but that after fusion with the BW5147 tumor line the hybrids began to actively secrete TsFz factor. Preliminary experiments suggest that antigen-primed mice possess a population of mature Ts3 cells that do not secrete TsFs unless activated with TsF2 factor. This resting Ts3 population presumably accounts for the bulk of the Tsz cells in antigenprimed mice. Thus, the NP responses of immune animals are not completely suppressed until sufficient Ts3 suppressor cells are activated to regulate the immune response.
The characterizaton of three distinct series of suppressor factors specific for the CS response to the NP hapten demonstrates the intricacy of the immunoregulatory pathway. The precise differences between the immunoregulatory molecules responsible for the communications between suppressor T cells is unknown. However, the potential availability of large quantities of monoclonal TsFa, TsFz, and TsF3 factors derived from both the C57BL/6 and CKB series of hybridoma lines should permit molecular comparisons among these functionally distinct T cell-derived products.
SLlmlTlary
Five hybridoma T cell lines were prepared by fusion of Ts3 cells with the BW5147 thymorna. The culture supernatants from these T cell hybrids contained a factor, TsFa, which specifically suppressed 4-hydroxy-3-nitrophenyl acetyl hapten (NP)-hapten cutaneous sensitivity responses. The properties of this new series of hybridoma factors was compared with those of two previously characterized types of NP-specific suppressor factors (TsF1 and TsF2). TsF3 activity was only observed if the factor was administered during the effector phases of the immune response. TsFz bears I-J and C57BL anti-NP antibody idiotypic determinants and has binding specificity for the NP hapten. Furthermore, TsFa does not suppress H-2 (I-J)-incompatible mice. In addition to this H-2 restriction, the monoclonal TsF3 factors also demonstrated an Igh genetic restriction. Finally, the TsF3 factors could be distinguished by their ability to suppress cyclophosphamide-treated recipients.
